April 12, 2024- McKesson recently conducted a Q&A with Kelly Williby, Vice President of Ambulatory Surgery Center and Community Health Center Sales, on ASCs and GPO maximization. Kelly Williby, VP of Ambulatory Surgery Center and Community Health Center Sales at McKesson Medical-Surgical, leads our team of ASC directors. According to Williby, "a Group Purchasing … [Read more...]

April 12, 2024- Pfizer Inc. announced positive top-line immunogenicity and safety data from the ongoing pivotal Phase 3 clinical trial (NCT05842967) MONeT (RSV IMmunizatiON Study for AdulTs at Higher Risk of Severe Illness),evaluating a single dose of ABRYSVO versus placebo in adults 18 to 59 years of age at risk of developing severe respiratory syncytial virus … [Read more...]

April 12, 2024- QuidelOrtho Corporation has added the ARK™ Fentanyl II Assay to its U.S. Vitros® XT 7600 and 5600 Integrated Systems as well as its Vitros® 4600 Chemistry System menu of assays as a MicroTip® Partnership Assay (“MPA”). This Fentanyl assay will help hospital and emergency room customers respond to the critical demand for enhanced opioid testing, … [Read more...]

April 12, 2024- The Collective Healthcare Action to Reduce MedTech Emissions (CHARME) collaborative launched with the goal of reducing greenhouse gas emissions that arise from the multi-billion dollar U.S. medical device and equipment supply chain. The MedTech (medical device, equipment, service, and distribution) supply chain accounts for 7% of U.S. health care greenhouse … [Read more...]

April 12, 2024- BD announced that it will receive the Business Group on Health "Best Employers: Excellence in Health & Well-being Award" for its commitment to advancing employee well-being through comprehensive and innovative benefits and initiatives. BD also garnered honors for "Excellence in Global Health & Well-being" for its ability to meet the diverse needs of … [Read more...]

April 11, 2024- Medtronic plc announced positive clinical trial safety and efficacy results for Sphere-360™, an investigational single-shot mapping and ablation catheter using pulsed field (PF) energy, for treatment of patients with paroxysmal atrial fibrillation (AFib). Interim findings from the first-in-human Sphere-360 study were presented as a late-breaking clinical trial … [Read more...]

April 11, 2024- Henry Schein, Inc. announced it has completed the acquisition of TriMed, Inc., a global developer of solutions for the orthopedic treatment of lower extremities (foot and ankle) and upper extremities (primarily hand and wrist). Henry Schein announced the agreement to acquire a majority interest of TriMed on December 20, 2023. The addition of … [Read more...]

April 11, 2024- Ansell announced it has entered into a binding agreement to acquire 100% of the assets that constitute Kimberly-Clark’s Personal Protective Equipment business (KCPPE) for US $640 million. The Acquisition is expected to complete by September 2024. With this Acquisition the company is enhancing sales of specialist products designed for clean room applications … [Read more...]

April 11, 2024- New findings from Cleveland Clinic and Tufts University researchers show high blood levels of TMAO (trimethylamine N-oxide) predicts future risk of developing chronic kidney disease over time. The findings build on more than a decade of research spearheaded by Stanley Hazen, M.D., Ph.D., and a team related to the gut microbiome’s role in cardiovascular health … [Read more...]

April 11, 2024- Thermo Fisher Scientific introduced its newest line of high performance, ultra-low temperature (ULT) freezers for cold storage lab equipment. With enhancements to performance, user experience and energy efficiency, the Thermo Scientific™ TSX™ Universal Series ULT Freezers adapt to scientists’ workflows across a variety of lab settings. Laboratories … [Read more...]